Ignite Creation Date:
2024-06-16 @ 11:49 AM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06433765
Status:
RECRUITING
Last Update Posted:
2024-07-03
First Post:
2024-05-23
Brief Title:
A Study Evaluating the Effect of BRIUMVI Ublituximab on Pregnancy and Infant Outcomes in Participants With Multiple Sclerosis MS
Sponsor:
TG Therapeutics Inc
Organization:
TG Therapeutics Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-03-26
Start Date Type:
ACTUAL
Primary Completion Date:
2025-06-28
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-06-28
Completion Date Type:
ESTIMATED
First Submit Date:
2024-05-23
First Submit QC Date:
May 23 2024
Study First Post Date:
2024-05-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-02
Last Update Post Date:
2024-07-03
Last Update Post Date Type:
ACTUAL